Comments on: Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease Conference https://insideout.vn/acumen-pharmaceuticals-presents-innovative-trial-screening-advancements-utilizing-ptau217-assay-in-phase-2-study-of-sabirnetug-for-early-alzheimers-disease-at-the-17th-annual-clinical-trials/ Inside Out Thu, 31 Oct 2024 12:17:50 +0000 hourly 1 https://wordpress.org/?v=6.6.2